Non-Hodgkin lymphoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:
* In the year 2018  the incidence of non-Hodgkin lymphoma was estimated to be 74680.
* In the year 2018  the incidence of non-Hodgkin lymphoma was estimated to be 74680.


* Between  2010-2014, the incidence of non-Hodgkin lymphoma was estimated to be 19 cases per 100,000 individuals in the United States.<ref>Adult Non-Hodgkin Lymphoma Treatment. National Cancer Institute. http://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq Accessed on October 1, 2015</ref>
* Between  2010-2014, the incidence of non-Hodgkin lymphoma was estimated to be 19 cases per 100,000 individuals in the United States.<ref name="urlAmerican Cancer Society | Cancer Facts & Statistics">{{cite web |url=https://cancerstatisticscenter.cancer.org/#!/cancer-site/Non-Hodgkin%20lymphoma |title=American Cancer Society &#124; Cancer Facts & Statistics |format= |work= |accessdate=}}</ref><ref>Adult Non-Hodgkin Lymphoma Treatment. National Cancer Institute. http://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq Accessed on October 1, 2015</ref>
* The delay-adjusted [[incidence]] of non-Hodgkin lymphoma in 2011 was estimated to be 20.2 per 100,000 individuals in the United States.<ref name="pmid25655604">{{cite journal |vauthors=Chiu BC, Hou N |title=Epidemiology and etiology of non-hodgkin lymphoma |journal=Cancer Treat. Res. |volume=165 |issue= |pages=1–25 |date=2015 |pmid=25655604 |doi=10.1007/978-3-319-13150-4_1 |url=}}</ref>
* The delay-adjusted [[incidence]] of non-Hodgkin lymphoma in 2011 was estimated to be 20.2 per 100,000 individuals in the United States.<ref name="pmid25655604">{{cite journal |vauthors=Chiu BC, Hou N |title=Epidemiology and etiology of non-hodgkin lymphoma |journal=Cancer Treat. Res. |volume=165 |issue= |pages=1–25 |date=2015 |pmid=25655604 |doi=10.1007/978-3-319-13150-4_1 |url=}}</ref>
* In 2011, the age-adjusted [[incidence]] of non-Hodgkin lymphoma was 19.63 per 100,000 individuals in the United States.<ref name="pmid25655604">{{cite journal |vauthors=Chiu BC, Hou N |title=Epidemiology and etiology of non-hodgkin lymphoma |journal=Cancer Treat. Res. |volume=165 |issue= |pages=1–25 |date=2015 |pmid=25655604 |doi=10.1007/978-3-319-13150-4_1 |url=}}</ref>
* In 2011, the age-adjusted [[incidence]] of non-Hodgkin lymphoma was 19.63 per 100,000 individuals in the United States.<ref name="pmid25655604">{{cite journal |vauthors=Chiu BC, Hou N |title=Epidemiology and etiology of non-hodgkin lymphoma |journal=Cancer Treat. Res. |volume=165 |issue= |pages=1–25 |date=2015 |pmid=25655604 |doi=10.1007/978-3-319-13150-4_1 |url=}}</ref>

Revision as of 16:24, 27 December 2018

Non-Hodgkin lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Non-Hodgkin's Lymphoma

Differentiating Non-Hodgkin Lymphoma from Other Diseases
Differentiating Types of Non-Hodgkin's Lymphoma

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Non-Hodgkin lymphoma epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Non-Hodgkin lymphoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Non-Hodgkin lymphoma epidemiology and demographics

CDC on Non-Hodgkin lymphoma epidemiology and demographics

Non-Hodgkin lymphoma epidemiology and demographics in the news

Blogs on Non-Hodgkin lymphoma epidemiology and demographics

Directions to Hospitals Treating Non-Hodgkin lymphoma

Risk calculators and risk factors for Non-Hodgkin lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2], Sowminya Arikapudi, M.B,B.S. [3]

Overview

Non-Hodgkin lymphoma (NHL) accounts for about 4% of all cancers in the United States. American cancer society statistic center estimates the incidence of non Hodgkin's lymphoma as 74680 in the year 2018, the incidence rate was estimated to 19 in 100,000 individuals in the years 2010-2014. The age-adjusted prevalence of non-Hodgkin lymphoma is 131.1 per 100,000 individuals in 2011.

Epidemiology and Demographics

Prevalence

  • In the United States, the age-adjusted prevalence of non-Hodgkin lymphoma is 131.1 per 100,000 individuals in 2011.[1]

Incidence

  • In the year 2018 the incidence of non-Hodgkin lymphoma was estimated to be 74680.
  • Between 2010-2014, the incidence of non-Hodgkin lymphoma was estimated to be 19 cases per 100,000 individuals in the United States.[2][3]
  • The delay-adjusted incidence of non-Hodgkin lymphoma in 2011 was estimated to be 20.2 per 100,000 individuals in the United States.[1]
  • In 2011, the age-adjusted incidence of non-Hodgkin lymphoma was 19.63 per 100,000 individuals in the United States.[1]

Age

  • While the overall age-adjusted incidence of non-Hodgkin lymphoma in the United States between 2007 and 2011 is 19.7 per 100,000 individuals, the age-adjusted incidence of non-Hodgkin lymphoma by age category is:[4]
    • Under 65 years: 9.3 per 100,000
    • 65 and over: 91.5 per 100,000
  • Shown below is an image depicting the incidence of non-Hodgkin lymphoma by the age of diagnosis in males in the United States between 1975 and 1977 as well as between 2009 and 2011.[4]

Incidence of non Hodgkin lymphoma by the age of diagnosis in males, USA.PNG

Gender

  • Males are more commonly affected with non-Hodgkin lymphoma than females
  • In the United States, the age-adjusted prevalence of non-Hodgkin lymphoma by gender in 2011 is:[4]
    • In males: 150.4 %
    • In females: 114.3 %
  • In the United States, the delay-adjusted incidence of non-Hodgkin lymphoma by gender in 2011 is:[4]
    • In males: 24.77 per 100,000 individuals
    • In females: 16.58 per 100,000 individuals
  • In the United States, the age-adjusted incidence of non-Hodgkin lymphoma by gender on 2011 is:[4]
    • In males: 24.07 per 100,000 individuals
    • In females: 16.11 per 100,000 individuals
  • Shown below is an image depicting the delay-adjusted incidence and observed incidence of non-Hodgkin lymphoma by gender and race in the United States between 1975 and 2011. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[4]

Delay-adjusted incidence and observed incidence of non-Hodgkin lymphoma by gender and race in the United States between 1975 and 2011

Race

  • Shown below is a table depicting the age-adjusted prevalence of non-Hodgkin lymphoma by race in 2011 in the United States.[1]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 131.1 per 100,000 141.2 per 100,000 95.3 per 100,000 83.5 per 100,000 101.4 per 100,000
  • Shown below is an image depicting the incidence of non-Hodgkin lymphoma by race in the United States between 1975 and 2011.[4]

Incidence of non-Hodgkin lymphoma by race in the United States between 1975 and 2011

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

References

  1. 1.0 1.1 1.2 1.3 Chiu BC, Hou N (2015). "Epidemiology and etiology of non-hodgkin lymphoma". Cancer Treat. Res. 165: 1–25. doi:10.1007/978-3-319-13150-4_1. PMID 25655604.
  2. "American Cancer Society | Cancer Facts & Statistics".
  3. Adult Non-Hodgkin Lymphoma Treatment. National Cancer Institute. http://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq Accessed on October 1, 2015
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.

Template:Hematology


Template:WikiDoc Sources